Infected Pancreatic Pseudocysts: Surgical Treatment

Introduction. The incidence of pancreatic pseudocysts (PPC) amounts to 0.5–1 per 100,000 adults per year. In all the pancreatic disorders the incidence of PPC amounts to 1.6-4.5%. Designing an individually tailored treatment programme using minimally invasive techniques to ensure the longest lasting treatment effect combined with the reduction of surgical trauma is an important issue of today’s surgery.

Materials and methods. This paper presents a retrospective analysis of surgeries performed on 101 patients with infected PPC treated in the period from 2000 to 2015 at surgical wards of the Centre for Emergency and Disaster Medicine of the Regional Teaching Hospital, Kharkiv, Ukraine and the Department of Pancreatic and Bile Duct Surgery of A. A. Shalimov National Institute of Surgery and Transplantology, Kyiv, Ukraine. Of these, 74 patients (73.3%) were male and 27 (26.7%) — female, aged 21 to 79, average age of patients was 43.3±1.2 years.

Results. Percutaneous drainage was administered to patients with type I infected PPC with the onset of multiple organ failure in order to make the wait-and-see strategy possible and to alleviate the patient’s general condition and improve the course of sepsis. For patients with type II and III infected PPC percutaneous punctures were the final stage of treatment in 80% of cases. Whether radical surgical procedures were performed depended on the severity of the patient’s condition, degree of pancreatic necrosis or chronic pancreatitis spread, PC localisation, duct system condition and complications involving neighbouring organs.

Conclusion. When treating patients with PPC one has to use an individually tailored treatment strategy based on state of the art minimally invasive treatment techniques. When treating infected PPC both minimally invasive and traditional open access procedures have to be considered as mutually complementing, presenting a broad range of diagnostic and treatment options.

1. Banks P.A., Bollen T.A., Dervenis Ch., Gooszen H.G., Johnson C.D., Sarr M.G., et al. Classification of acute pancreatitis — 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11. DOI: 10.1136/gutjnl-2012-302779

2. Pasin F., Tanzi G., Grassia R. Abdominal wall pseudocyst fluid collection: the unexpected presentation of pancreatic pseudocyst. Intern Emerg Med. 2018;13(5):801–3. DOI: 10.1007/s11739-018-1830-1

3. Pugaev A.V., Achkasov E.E. Acute pancreatitis. Moscow: INFRAM; 2019 (In Russ.) DOI: 10.12737/monography_5bac927d4a 2f73.37500387

4. Rosenberg A., Steensma E.A., Napolitano L.M. Necrotizing pancreatitis: new definitions and a new era in surgical management. Surg Infect (Larchmt). 2015;16(1):1–13. DOI: 10.1089/sur.2014.123

5. Aliev S.A., Bayramov N.Yu., Aliev E.S. Infected pancreatic necrosis: state of the problem and alternative approaches for surgical treatment. Literature review. Herald of surgical gastroenterology. 2015;(1–2):75– 83 (In Russ.).

6. da Costa D.W., Boerma D., van Santvoort H.C. Staged multidisciplinary step-up management for necrotizing pancreatitis. Br J Surg. 2014;101(1):65–79. DOI: 10.1002/bjs.9346

7. Rasch S., Notzel B., Phillip V., Lahmer T., Schmid R.M., Algul H. Management of pancreatic pseudocysts-A retrospective analysis. PLoS One. 2017;12(9):e0184374. DOI: 10.1371/journal.pone.0184374

8. Khatsko V.V., Zenin O.K., Potapov V.V. Surgical tactics in cases of pancreatic pseudocysts. University proceedings. Volga region. Medical sciences. 2015;(3):127–34 (In Russ.).

9. Yao Y., Zhang D., Guo J., Qi K., Li F., Zhu J., et al. A novel self-expanding biflanged metal stent vs tubular metal stent for EUS-guided transmural drainage of pancreatic pseudocyst: A retrospective, cohort study. Medicine. 2019;98(3):e14179. DOI: 10.1097/MD.0000000000014179

10. Rebrov A.A., Semenov D.Y., Vasiliyev V.V., Gunya Z.A., Mel’nikov V.V., Vaganov A.A. Percutaneous interventions in patients with pancreatic pseudocysts. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery. 2017;22(1):49–54 (In Russ.). DOI: 10.16931/1995-5464.2017149-54

11. Zhu H., Jiang F., Zhu J., Du Y., Jin Z., Li Z. Assessment of morbidity and mortality associated with endoscopic ultrasound-guided fine-needle aspiration for pancreatic cystic lesions: A systematic review and metaanalysis. Dig Endosc. 2017;29(6):667–75. DOI: 10.1111/den.12851

12. Brugge W.R. Diagnosis and management of cystic lesions of the pancreas. J Gastrointest Oncol. 2015; 6(4): 375–88. DOI: 10.3978/j. issn.2078-6891.2015.057

13. Udeshika W.A.E., Herath H.M.M.T.B., Dassanayake S.U.B., Pahalagamage S.P., Kulatunga A. A case report of giant pancreatic pseudocyst following acute pancreatitis: experience with endoscopic internal drainage. BMC Research Notes. 2018;11(1):262. DOI: 10.1186/s13104018-3375-9

14. Bykova Y.F., Solovev M.M., Fatyshina O.A., Rudenko T.O. Аssessment of tactics of operative treatment of pancreatic pseudocyst. Siberian Medical Journal. 2014;124(1):53–7 (In Russ.).

15. Dumonceau J.M., Andriulli A., Elmunzer B.J., Mariani A., Meister T., Deviere J., et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline — updated June 2014. Endoscopy. 2014;46(9):799–815. DOI: 10.1055/s-0034-1377875

16. Shah A.P., Mourad M.M., Bramhall S.R. Acute pancreatitis: current perspectives on diagnosis and management. J Inflamm Res. 2018;11:77–85. DOI: 10.2147/JIR.S135751

17. Lee H.C., Tse K.H. Pancreatic pseudocyst rupture into the portal vein diagnosed by magnetic resonance imaging. Hong Kong Medical Journal. 2018;24(2):206.e1–2. DOI: 10.12809/hkmj164980

18. Kim H.J., Jun C.H., Park C.H., Cho C.K. Intrahepatic pancreatic pseudocyst complicated by pancreatitis: a case report. Korean J Gastroenterol. 2017;70(4):202–7. DOI: 10.4166/kjg.2017.70.4.202

19. Nesvaderani M., Eslick G.D., Faraj S., Vagg D., Cox M.R. Study of the early management of acute pancreatitis. ANZ J Surg. 2017;87(10):805– 9. DOI: 10.1111/ans.13330